Vantage Oncology, a developer and operator of radiation oncology centers, has completed seven new partnerships comprising 10 cancer treatment facilities in several new and existing markets.
In addition, Vantage has secured a new $100 million credit facility to support the company's continued growth. Vantage now operates 31 centers in 11 states with its physician and hospital partners.
The 10 new centers include: Radiation Medicine Specialists of Northeast PA in Wilkes-Barre, Pa.; Comprehensive Oncology Care in Exton, Pa.; Northern Boulevard Radiation Oncology Associates in Queens, N.Y.; and Cancer Care Centers of Brevard in Brevard and Indian River counties in Florida.
Additionally, Vantage has opened three new centers: Glendale Radiation Oncology in Glendale, Calif.; Rowlett Regional Cancer Center in Rowlett, Texas; and Streator Radiation Oncology in Streator, Ill.
The new $100 million credit facility has been provided by Ares Capital. The debt capital combined with equity capital from all five existing equity investors, New Enterprise Associates, CCP Equity Partners, Versant Ventures, Salix Ventures and Camden Partners, will be used to further expand its network of centers, according to the Manhattan Beach, Calif.-based Vantage.